Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
International Journal of Rheumatic Diseases|April 4, 2018
Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetilYoung Bin Joo, Young Mo Kang, Hyoun-Ah Kim, et al.
The Korean Journal of Internal Medicine|January 17, 2018
Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritisHan Joo Baek, Mie Jin Lim, Won Park, et al.
Rheumatology (Oxford, England)|August 12, 2023
Transcriptomic network analysis reveals key drivers of response to anti-TNF biologics in patients with rheumatoid arthritisChae-Yeon Yu, Hye-Soon Lee, Young Bin Joo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2010
Direct inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1betaBitnara Lee, Tae-Hwan Kim, Jae-Bum Jun, et al.
Arthritis and Rheumatism|May 30, 2009
Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosusYong-Wook Park, Seung-Jung Kee, Young-Nan Cho, et al.
Rheumatology International|February 20, 2017
Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximabYoon-Kyoung Sung, Soo-Kyung Cho, Dam Kim, et al.
International Journal of Rheumatic Diseases|March 7, 2017
Prevalence of co-morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross-sectional study (COMORA)In Ah Choi, Sung Hwan Park, Hoon-Suk Cha, et al.
Arthritis and Rheumatism|July 9, 2003
Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysisFotini B Karassa, Marc Bijl, Kevin A Davies, et al.
Scientific Reports|May 15, 2023
Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective studyYeo-Jin Song, Soo-Kyung Cho, Hyoungyoung Kim, et al.
Arthritis Research & Therapy|January 23, 2016
Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS studyWon Park, Dae Hyun Yoo, Janusz Jaworski, et al.
Pageof 15